We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

152 hedge funds and large institutions have $414M invested in Enanta Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 68 increasing their positions, 33 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 13

106% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 33

12% more funds holding

Funds holding: 136 → 152 (+16)

14% less capital invested

Capital invested by funds: $483M → $414M (-$68.5M)

19% less call options, than puts

Call options by funds: $1.63M | Put options by funds: $2M

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
152
Holders Change
+16
Holders Change %
+11.76%
% of All Funds
4.05%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
31
Increased
68
Reduced
33
Closed
13
Calls
$1.63M
Puts
$2M
Net Calls
-$373K
Net Calls Change
+$6.9M

Top Buyers

1
EC
EcoR1 Capital
California
+$6.69M
2
SAM
Senzar Asset Management
New York
+$4.87M
3
GAM
Gotham Asset Management
New York
+$2.47M
4
NI
Numeric Investors
Massachusetts
+$2.45M
5
AL
AJO LP
Pennsylvania
+$2.44M

Top Sellers

1
Invesco
Invesco
Georgia
-$16.1M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$11.1M
3
O
OrbiMed
New York
-$7.1M
4
MVM
McClain Value Management
Connecticut
-$4.14M
5
WRF
Waddell & Reed Financial
Kansas
-$3.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
151
Endurance Wealth Management
Rhode Island
$47 – – –
WRF
152
Waddell & Reed Financial
Kansas
– -$3.65M -110,500 Closed
American Century Companies
153
American Century Companies
Missouri
– -$2.61M -79,158 Closed
LSV Asset Management
154
LSV Asset Management
Illinois
– -$2.38M -72,200 Closed
SCM
155
Stonepine Capital Management
Oregon
– -$2.35M -71,147 Closed
CCM
156
Cadence Capital Management
Massachusetts
– -$531K -16,080 Closed
WBC
157
Westpac Banking Corp
Australia
– -$382K -11,580 Closed
ACI
158
AMP Capital Investors
Australia
– -$261K -7,800 Closed
ASRS
159
Arizona State Retirement System
Arizona
– -$211K -6,400 Closed
IA
160
IFP Advisors
Florida
– -$57K -1,714 Closed
FCCM
161
First City Capital Management
Georgia
– -$38K -1,150 Closed
Creative Planning
162
Creative Planning
Kansas
– -$1K -37 Closed
Fifth Third Bancorp
163
Fifth Third Bancorp
Ohio
– -$1K -37 Closed
CCA
164
Checchi Capital Advisers
California
– +$195 +7 New
3 4 5 6
7

ENTA Hedge Fund Activity: Q1 2016 in Review

152 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q1 2016, worth a combined $414M — down 14% from $483M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ENTA positions and 13 closed out — a net gain of 18 holders — while 68 added to existing stakes and 33 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $6.69M. The largest seller was Invesco, cutting an estimated $16.1M.

  • 152 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q1 2016, up from 136 in Q4 2015.
  • Funds reported $414M of Enanta Pharmaceuticals stock for Q1 2016, down 14% quarter-over-quarter.
  • 31 funds opened new Enanta Pharmaceuticals positions in Q1 2016 and 13 closed out, a net change of +18 holders.
  • The largest Enanta Pharmaceuticals buyer in Q1 2016 was EcoR1 Capital, an estimated $6.69M added.
  • The largest Enanta Pharmaceuticals seller in Q1 2016 was Invesco, an estimated $16.1M sold.

Based on aggregated 13F filings for Q1 2016.